Stay updated on ELAD Safety and Efficacy in AILD Clinical Trial

Sign up to get notified when there's something new on the ELAD Safety and Efficacy in AILD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ELAD Safety and Efficacy in AILD Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    No significant changes observed in core study details or page structure; the page sections (Study Overview, Eligibility Criteria, Study Plan, and Locations) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-18T07:50:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; lapse-in-government-funding notice and the v3.4.1 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T09:16:47.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a government funding lapse notice and updates the version label to v3.4.1, while removing the previous v3.4.0 label. These changes do not modify core study information such as eligibility, endpoints, or results; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T05:21:28.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Additions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T03:50:38.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown, replacing the previous v3.3.3. This appears to be a minor page version update with no changes to the study content or data.
    Difference
    0.0%
    Check dated 2026-01-14T01:46:19.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added the Locations section with numerous study sites (Arkansas, California, Florida, Georgia, Illinois, Maryland, Massachusetts, Minnesota, Missouri, New Jersey, New York, Ohio, Pennsylvania, Texas, Virginia, Wisconsin, Styria, Bavaria, Madrid, England, Scotland) and updated the revision to v3.3.3; removed the HHS Vulnerability Disclosure section and older location entries.
    Difference
    1%
    Check dated 2025-12-23T08:51:12.000Z thumbnail image

Stay in the know with updates to ELAD Safety and Efficacy in AILD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ELAD Safety and Efficacy in AILD Clinical Trial page.